165
BACKGROUND : Several studies have demonstrated liposomal doxorubicin ( Doxil ) to be an active antineoplastic agent in platinum - resistant ovarian cancer , with dose limiting toxicity of the standard dosing regimen ( 50 mg / m ( 2 ) q 4 weeks ) being severe erythrodysesthesia ( " hand - foot syndrome " ) and stomatitis .
 Chemical: doxorubicin; Chemical: Doxil; Chemical: platinum; Disease: ovarian cancer; Disease: toxicity; Disease: erythrodysesthesia; Disease: hand - foot syndrome; Disease: stomatitis
Please list all entity words in the text that fit the category.Output format is "type1: word1; type2: word2". 
Option: Disease, Chemical 
Text: {0} 
Answer:
 Chemical: doxorubicin; Chemical: Doxil; Chemical: platinum; Disease: ovarian cancer; Disease: toxicity; Disease: erythrodysesthesia; Disease: hand - foot syndrome; Disease: stomatitis